Investegate |N4 Pharma PLC Announcements | N4 Pharma PLC: Result of AGM
Investegate announcements from N4 Pharma PLC, Result of AGM
Source: investegate.co.uk
📰 Pharma Plc News
Page 7 - Pharma Plc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Plc. Real-time updates on events, politics, business and more.
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December ...
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December ...
Source: pr-inside.com
Herantis Pharma Oyj : Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders 2023
Herantis Pharma Plc Company release Notice to Convene Herantis Pharma Plcs Annual General Meeting of Shareholders Herantis Pharma Plc ... | March 28, 2023
Source: marketscreener.com
Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. ... | March 27, 2023
Source: marketscreener.com
H.C. Wainwright Reaffirms Their Buy Rating on Verona Pharma (VRNA)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Verona Pharma (VRNA – Research Report) today and set a price target of $3...
Source: businessinsider.com
Propulsion of Asthma Pipeline as Novel and Extensive 95+ Therapies Likely to Enter in the Treatment Domain
/PRNewswire/ -- DelveInsights Asthma Pipeline Insight – 2023 report provides comprehensive global coverage of available, marketed, and pipeline asthma...
United Kingdom Evelo Biosciences Shruti Thakur Keymed Biosciences Verona Pharma Lanier Biotherapeutics
Source: prnewswire.com
DelveInsight Business Research, LLP: Propulsion of Asthma Pipeline as Novel and Extensive 95+ Therapies Likely to Enter in the Treatment Domain
Asthma is a chronic disease that affects a substantial number of patients worldwide, including children, a number of pharmaceutical companies are involved in developing drugs for asthma. This
Source: finanznachrichten.de
Investegate |4d Pharma PLC Announcements | 4d Pharma PLC: Cancellation of admission to trading on AIM
Investegate announcements from 4d Pharma PLC, Cancellation of admission to trading on AIM
Source: investegate.co.uk
N4 Pharma provides update on ongoing Australian Research Council grant work
N4 Pharma provides update on ongoing Australian Research Council grant work
Source: directorstalkinterviews.com
Lifshitz Law PLLC Announces Investigations of DCT, PAYA,
NEW YORK, Jan. 14, 2023 (GLOBE NEWSWIRE) -- Duck Creek Technologies, Inc. (NASDAQ: DCT) Lifshitz Law PLLC announces an investigation into possible...
Source: globenewswire.com